New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 23, 2014
08:23 EDTCBSTCubist Sivextro sales to benefit from lack of warnings, says JMP Securities
After the FDA approved Cubist's Sivextro treatment for skin infections, JMP Securities notes that the FDA did not require warnings about a number of potential serious side effects to be placed on the drug's label. The firm thinks the absence of these warnings should boost sales of the drug. It reiterates an Outperform rating on Cubist.
News For CBST From The Last 14 Days
Check below for free stories on CBST the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 18, 2014
11:41 EDTCBSTCubist rises after report sparks takeover interest speculation
Subscribe for More Information
09:43 EDTCBSTCubist may receive takeover interest, Bloomberg reports
Cubist Pharmaceuticals' (CBST) focus on bacterial infections could attract takeover interest, Bloomberg reports in its Real M&A column. Reference Link
August 8, 2014
17:49 EDTCBSTCubist issues voluntary nationwide recall of nine lots of CUBICIN
Subscribe for More Information
August 6, 2014
08:17 EDTCBSTCubist issues voluntary recall of certain lots of CUBICIN in the U.S.
Subscribe for More Information
06:22 EDTCBSTJefferies to hold a summit
Boston Healthcare Summit to be held in Boston on August 6.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use